0001493152-23-046131.txt : 20231226 0001493152-23-046131.hdr.sgml : 20231226 20231226160520 ACCESSION NUMBER: 0001493152-23-046131 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231226 EFFECTIVENESS DATE: 20231226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dare Bioscience, Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500747 FILM NUMBER: 231513358 BUSINESS ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-926-7655 MAIL ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Cerulean Pharma Inc. DATE OF NAME CHANGE: 20090714 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 D 1 primary_doc.xml X0708 D LIVE 0001401914 Dare Bioscience, Inc. 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA CALIFORNIA 92122 858-926-7655 DELAWARE None Cerulean Pharma Inc. Tempo Pharmaceuticals Inc Corporation true Sabrina Martucci Johnson 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Executive Officer Director Lisa Walters-Hoffert 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Executive Officer William H. Rastetter 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Cheryl R. Blanchard 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Jessica D. Grossman 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Susan L. Kelley 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Gregory W. Matz 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Sophia N. Ononye-Onyia 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Robin J. Steele 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Biotechnology Decline to Disclose 06b false 2023-12-21 true true true false 0 4160400 1733500 2426900 Total offering amount includes the $0.3467 per underlying share of common stock for up to 7,000,000 warrants to purchase common stock to be issued in the future, assuming certain conditions are met, and the aggregate exercise price of such warrants. false 1 0 0 0 false Dare Bioscience, Inc. /s/ Lisa Walters-Hoffert Lisa Walters-Hoffert Chief Financial Officer 2023-12-26